BRIEF-Cellectis shares rise 50 pct after Pfizer deal

PARIS, June 18 Wed Jun 18, 2014 3:15am EDT

Related Topics

PARIS, June 18 (Reuters) - Cellectis SA : * Shares rise 50 percent after signs deal with Pfizer to develop

immunotherapy drugs in cancer

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.